TrialJournal of the American Heart Association2024

Percutaneous Coronary Interventions Using a Ridaforolimus-Eluting Stent in Patients at High Bleeding Risk.

Ran Kornowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.